Adducin α Double Nickase Plasmid (h): sc-401693-NIC
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- Adducin α Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- Adducin α Double Nickase Plasmid (h) and Adducin α Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting ADD1. One or both designs may be available
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: Adducin α Antibody (4D1): sc-33633
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Adducin α Double Nickase Plasmid (h) | sc-401693-NIC | 20 µg | $410.00 | |||
Adducin α Double Nickase Plasmid (h2) | sc-401693-NIC-2 | 20 µg | $410.00 |
ADD1 encodes adducin α, a membrane-skeletal protein that caps and bundles actin filaments and promotes spectrin–actin network assembly at the cell cortex. Through regulation of cytoskeletal organization, cell shape, and membrane stability, adducin α contributes to processes such as cell adhesion, motility, and mechanical resilience in erythrocytes and other cell types. Its activity is modulated by phosphorylation-dependent signaling, including protein kinase C and Rho family pathways that tune actin remodeling and cortical tension. Dysregulation of ADD1-associated cytoskeletal dynamics has been studied in relation to altered membrane properties and blood pressure–related phenotypes, supporting its use as a target in mechanobiology and vascular cell research.
Adducin α Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the ADD1 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within ADD1. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt ADD1 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of ADD1-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.